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The  increase  of  anthelmintic  resistance  in  the last  years  in  the  nematode  population  of
veterinary importance  has  become  a major  concern.  The  objective  of  the  present  study  was
to  evaluate  the efﬁcacy  of the  main  anthelmintic  drugs  available  in the  market  against  small
strongyles of horses  in Brazil.  A total  of  498 horses  from  11  horse  farms,  located  in the  states
of  Paraná,  São Paulo,  Rio  de Janeiro  and  Minas  Gerais,  in  Brazil,  were  treated  with  ivermectin,
moxidectin,  pyrantel  and  fenbendazole,  orally  at their  recommended  doses.  The  fecal  egg
count  reduction  test  (FECRT)  was  used  to  determine  the  product’s  efﬁcacy  and  fecal  culture
was  used  to  determine  the  parasite  genus.  Reduction  on  anthelmintic  efﬁcacy  was  found
for fenbendazole  in  all horse  farms  (11/11),  pyrantel  in  ﬁve  yards  (5/11)  and  ivermectin  hadmall strongyles
nthelmintic resistance
low  efﬁcacy  in one  of the yards  studied  (1/11).  Multidrug  resistance  of up  to  3  drugs  classes
was found  in  one  of the  tested  farms  (1/11).  Cyathostomin  were  the  most  prevalent  parasite.
The  results  showed  that  resistance  to fenbendazole  is  widespread;  the  efﬁcacy  of  pyrantel
is in  a  critical  situation.  Although  the macrocyclic  lactones  compounds  still  showed  high
efﬁcacy  on most  farms,  suspected  resistance  to  macrocyclic  lactones  is  of  great  concern.
Open access under the Elsevier OA license.. Introduction
Intestinal helminths are considered an important cause
f disease in horses. The group belonging to the Cyathos-
ominae subfamily (small strongyles) is the most common
nfecting horses (Matthews et al., 2004). Cyathostomin are
arasites of cecum and colon, which encysts in the intesti-
al mucosa in the form of L3/L4 (third and fourth stage
arvae) after the infection and are highly pathogenic when
resent in high numbers. The damage on the intestinal
all occurs when the L4 develops and emerge through
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the intestinal tissue. Clinical signs may  result in lethargy,
weight loss, potentially serious colic, diarrhea, and death.
Large numbers of adult worms  also may  cause symp-
toms such as lethargy, debilitation and diarrhea, but when
they are present in a few numbers, the infection may  be
asymptomatic (Klei and Chapman, 1999; Love et al., 1999;
Corning, 2009).
Parasite control in racehorses is usually performed
with suppressive treatment several times throughout the
year, using mainly the benzimidazoles, pyrimidine and
the macrocyclic lactones (Traversa, 2008). These strategies
resulted in the selection of drug resistant parasites, espe-
cially the cyathostomin against fenbendazole and pyrantel,
and in many other places these drugs have little or no effec-
tiveness (Kaplan, 2002). A lack of efﬁcacy of the macrocyclic
lactones in small strongyles has been reported recently,
and this evidence is a threat to the health and the welfare
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of the animals in many countries (Molento et al., 2008;
Traversa et al., 2009). Resistance to macrocyclic lactones
was reported to Parascaris equorum, and piperazine is being
used to treat foals and yearlings to avoid the high mortal-
ity (Slocombe et al., 2003; Reinemyer, 2008). The control
of small strongyles parasites has become very challeng-
ing, due to the continuous use of suppressive treatment
intervals mainly in intensive stud farms in Brazil (Molento,
personal observation, 2011). The objective of the present
study was to evaluate the efﬁcacy of four anthelmintic
drugs against cyathostomin in horses from four Brazilian
states.
2. Materials and methods
The study was performed in 11 horse farms, four on
the State of Paraná (Campina Grande do Sul: PR1, Porto
Amazonas: PR2 and PR3, and São José dos Pinhais: PR4),
three from São Paulo (Bauru: SP1, Brotas: SP2, São José
do Rio Pardo: SP3), two from Minas Gerais (Inconﬁdentes:
MG1, Inhaúma: MG2) and two from Rio de Janeiro (Mar-
icá: RJ1, Teresópolis: RJ2). The experiment took place from
November 2009 to July 2010. A fecal screening test was
performed in 694 horses and we selected 498 horses for
the study. We  selected males and females, (1) animals
that were older than 12 months; (2) that were considered
healthy after clinical examination, and; (3) that had fecal
egg counts (EPGs) above 100. All animals did not receive
any anthelmintic treatment 60 days prior the fecal egg
count reduction test (FECRT).
Drug efﬁcacy was evaluated for fenbendazole, pyran-
tel pamoate, ivermectin and moxidectin, all formulated for
oral use in horses at their manufactures’ recommended
dose rates. The animals were randomly included in one of
the four groups (n = 8), from a total of 32 horses at least for
each horse farm. All horses were sampled on day −10 to
determine the EPG, using the modiﬁed McMaster method
(Gordon and Whitlock, 1939) with detection limit of 25 in
duplicates for each sampled animal. Animals were sampled
for EPG and treated on day 0 by a local veterinary practi-
tioner. Fecal samples were taken on day 14 post-treatment
to perform the FECRT (Coles et al., 1992).
An aliquot of 50 g from the fecal samples from the pre
and post-treatment was used to culture to obtain the preva-
lence of cyathostomin. The material was incubated at 28 ◦C
under 70–90% humidity for 8 days and larvae were recov-
ered using Baerman apparatus and identiﬁed according to
Bevilaqua et al. (1993).
A questionnaire was applied to all horse own-
ers/managers with the objective to correlate the parasite
control strategies with the possible reduction of drug
efﬁcacy. The questions addressed general managements
of horse farms, the sanitary management, mainly for
anthelmintic treatment, dosing frequency, if treatment
includes all horses, fecal examinations, the drugs used and
rotation.
FECRT was performed using the EPG from day 0 and day
14 from the same animal, with RESO 2.0 Analysis Program
(Wursthorn and Martin, 1990). The criteria for resistance
was considered when the FECRT was <95% and the lower
conﬁdence limit (LCL) was below 90% for fenbendazole,sitology 194 (2013) 35– 39
ivermectin and moxidectin. For pyrantel resistance was
considered when the FECRT was <90% and the LCL was
below 80%. Resistance was  suspected when only one situa-
tion was  found only one of both situation described above
was  found (Dargatz et al., 2000; Pook et al., 2002; Kaplan
and Nielsen, 2010).
3. Results
The efﬁcacy results are described on Table 1. Consid-
ering the values of conﬁdence interval, all horse farms
showed fenbendazole resistance. The resistance to pyrantel
was  determined in 5 horse farms. Resistance to ivermectin
was  found in 1 farm and 3 had reduced efﬁcacy. Mox-
idectin resistance was not found, but efﬁcacy under 100%
was  found in 5 farms, ranging from 96 to 99%.
At the horse farms where we  found resistance to two
drugs, the management data revealed that horses in the
yard were treated at 2-month interval or less and the
farmer did not rotate pastures.
The two horse farms (SP2 and RJ2) that we  found
anthelmintic resistance only to fenbendazole and a high
efﬁcacy to pyrantel, reported that the main management
strategy was to dose the animals after long treatment inter-
vals of more than 90 days, and on farm SP2 the treatment
was  performed only after EPG counts in the animals and
the farmer kept animals on separated pastures depending
on the different categories (mares, foals, training horses).
On RJ2 incoming animals were treated and maintained
restricted for at least ﬁve days before incorporated with
the other animals. The data collected from the other farms
described a similar set of management strategies where the
owners were clearly following a more suppressive treat-
ment scheme for parasite control/eradication, treating all
the animals on the same time and at short term intervals
of 2-3 months.
The larvae (L3) identiﬁcation revealed that the cyathos-
tomin were the most prevalent in pre and post treatment,
ranging from 76% to 100% and 84% to 100%, with an average
of 91% and 94% between the yards, respectively. New anal-
ysis will be performed to determine the level of resistance
to Strongylus vulgaris (8 farms) and S. edentatus (5 farms)
(data not shown).
4. Discussion
Cyathostomin resistance to benzimidazoles, especially
thiabendazole and fenbendazole is widespread and was
reported by Lyons et al. (2007) in studies conducted over
40 years in Kentucky (USA). In Germany, Drogemuller et al.
(2004) performed 45 FECRT with fenbendazole gradually
increasing the dosage between 7.5 and 30 mg/kg and in
all results the efﬁcacy was lower than 90% and Wirtherle
et al. (2004) found fenbendazole resistance in 10 horse
farms. In United Kingdom, Germany and Italy resistance to
fenbendazole was  also reported by Traversa et al. (2009).
Resistance to fenbendazole was found in 76.9% of the yards
in Sweden, with 23.1% reported suspected resistant cases
(Lind et al., 2007). von Samson-Himmelstjerna et al. (2002)
reported fenbendazole resistance using FECRT in three
farms (27; 26.5; and 83.9%) in Chile. In Brazil, the low
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Table 1
Efﬁcacy of febendazole, pyrantel, ivermectin and moxidectin in 11 horse farms from four Brazilian states.
Horse farms Percentage of efﬁcacy and lower conﬁdence limit (%)
FBZ LCL PYR LCL IVC LCL MOX  LCL
MG1  14 −52 66 20 99 96 96 88
MG2  61 −24 89 50 96 69 100 100
PR1  −65 −230 94 84 100 98 99 97
PR2  −18 −210 59 −103 89 41 100 100
PR3 −285  −768 93 81 99 87 98 91
PR4 −56  −488 79 −45 96 86 99 94
SP1 12 −63  96 83 99 96 100 100
SP2 29  −51 99 96 98 96 100 98
SP3  −249 −631 69 −44 100 100 100 100
RJ1  40 −49 94 82 100 98 98 93
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Variation 0–61 59–99 
fﬁcacy of benzimidazole was previously reported in three
orse farms by Luz Pereira et al. (1994).  Otto et al. (2008)
nd Molento et al. (2008) reported low efﬁcacy against
enbendazole (84% and XX%, respectively) using FECRT in
he South of Brazil. The present study revealed a great
fﬁcacy variation for pyrantel (59-99%) where resistance
r suspected resistance was determined in nine studs.
lthough the resistance to pyrantel has not being exten-
ively reported as the benzimidazoles, we consider that
he resistance threshold and conﬁdence interval should be
ore conservative, considering the 90% efﬁcacy value and
CL of 80% to this drug family. Resistance to pyrantel was
lso described in Denmark (Craven et al., 1998; Nielsen,
009), USA (Chapman et al., 1996; Kaplan et al., 2004),
nited Kingdom (Coles et al., 1992; Traversa et al., 2009),
taly and Germany (Traversa et al., 2009), Brazil (Molento
t al., 2008).
The resistance to ivermectin and moxidectin causes
reat concern against small strongyles. We  found marginal
evels of efﬁcacy for ivermectin in 3 farms. Many authors
eported a continuation of the high efﬁcacy of macro-
yclic lactones (Otto et al., 2008; Slocombe et al., 2008;
ielsen, 2009; Traversa et al., 2009), but recent studies
eported cyathostomin resistance to the macrocyclic lac-
ones (Molento et al., 2008; Traversa et al., 2009).
Multidrug resistance (MDR) occurs when the drug
fﬁcacy failure is observed to more than two drugs simul-
aneously. Because of the limited number of available
ompounds for horse treatment, the diagnosis of MDR
arasites in this study means that practitioners have an
ven reduced number of anthelmintic compounds to use.
n this study we found side-resistance in ﬁve yards and
n one yard there was the involvement of three chemi-
al classes. Considering also that the marginal low efﬁcacy
ay  be an indication of the beginning of the resistance pro-
ess, the MDR  situation may  soon be a problem in other 3
arms.
MDR  was found previously in Brazil, including the
acrocyclic lactones (Molento et al., 2008). The authors
eported the failure of fenbendazole, pyrantel, iver-
ectin, moxidectin and abamectin against cyathostomins.
raversa et al. (2009) found efﬁcacy after treatment with
enbendazole in 38% of horse farms tested in Italy, 82.4%
n United Kingdom and 84.6% in Germany, resistance to92 100 100 100 98
89–100 96–100
pyrantel in 30% in Italy, 18.2% in United Kingdom and 20%
in Germany and resistance to ivermectin in 1.7% in Italy
and 9.1% in United Kingdom. Resistance to moxidectin was
suspected (lower than 100%) from only one horse farm in
Germany.
Although ivermectin and moxidectin still have high efﬁ-
cacy rates against cyathostomin, with high egg reduction
after treatment, Molento et al. (2008) found a less-than
to Small and Large Strongyles egg reappearance period
(ERP), that was originally 8 weeks for ivermectin and 12
(up to 22) weeks to moxidectin (Demeulenaere et al., 1997;
Dipietro et al., 1997) to both compounds. Recent studies
found the reduction of ERP after more than 4 weeks pos-
treatment (von Samson-Himmelstjerna et al., 2007; Lyons
et al., 2008, 2011; Rossano et al., 2010). Lyons et al. (2009)
described after a critical test that one of the probable rea-
sons of the development of the short ERP was  due to the
incomplete removal of luminal immature cyathostomins,
accelerating the beginning of the egg laying in less than
4 weeks.
Lyons et al. (2010) determined that the reduction on the
ERP for moxidectin could be also because of the remaining
immature L4 at necropsy after a lack of efﬁcacy (82-99%)
having 99-100% efﬁcacy against adults. Although, Cobb and
Boeckh (2009) suggested that the long ERP for moxidectin
may  be due to its effect against encysted L4 larvae in the
intestinal mucosa this fact may  also have a strong selec-
tion impact on the resident larvae that could represent a
much shorter lifespan for the drug once the homozygous
individuals start to be more prevalent into the popula-
tion.
Although recognizing that single drug resistance and
MDR  is the result of a complex set of variables, it is
being advocated that farm advisors adopt more sustain-
able control strategies with the objective of reducing
selection pressure to parasite populations. Thus, the sup-
pressive treatment performed by two horse farms where
we found MDR  isolates would be considered unsuitable
into todays’ regime. Molento (2005) pointed out that one
of the main challenges is to alert veterinarians about the
positive outcomes of using a drug-monitoring test based
on FECRT with the objective to identify and to maintain the
efﬁcacy of drugs and the adoption of management prac-
tices that can give priority to the refugia population. The
ry Para38 R.J. Canever et al. / Veterina
selective therapy that recommends treatment when EPG
value reaches 200 for foals and 500 for adult horses was
suggested as an alternative to reduce the selection pres-
sure of the parasite population and maintenance of refugia
in the ﬁeld (Coles and Molento, 2008). This strategy would
allow the spread of eggs by untreated parasites increas-
ing in chances for the refugia population. However very
little evidence exists evaluating the long-term effects of
anthelmintic treatment program using selective therapy,
and there are concerns about the possibility of Strongy-
lus vulgaris to become more prevalent in the horses that
receive little or no treatment due to their low EPG (Nielsen,
2009).
A possible reduction in the parasite selection may  be on
the way as reported by Larsen et al. (2011) in Denmark,
where the selective therapy was adopted and the legis-
lation now only allows anthelmintic treatment for horses
with an ofﬁcial veterinary prescription. As the drug sce-
nario in Denmark does not represent a worrisome situation
in terms of overall lack of efﬁcacy, the adoption of these
new rules will be reﬂected and will cause an impact after
10 or 20 years where the use of target treatment will avoid
parasite resistance and would then be used to compare
with other regions. In this special case we think that ﬁeld
veterinarians should receive constant training as control
strategies may  change during the process.
Two other practices have been extensively discussed
namely drug rotation and the use of drug combinations,
and taking the market situation and the drug range that is
available in Brazil both recommendations fall into the same
small basket of options. Molento (2005) reported that avail-
able macrolactones, ivermectin and abamectin, and now
moxidectin, have an option to be used with praziquantel,
a short-acting, large-spectrum compound. The problem is
that the involved companies removed praziquantel from
the market, pushing the veterinarians and farmers to adopt
the drug rotation (with their own product) and the use
of combos at the same time. Therefore, even spreading
the message discouraging the use of drug combos and
the fast drug-rotation strategies, we are facing with the
failure of slowing down the drug selection pressure on
farms.
5. Conclusion
It was possible to determine the lack of efﬁcacy of the
main anthelmintic drugs used in horses and to demon-
strate the high prevalence of MDR  on small strongyles from
four Brazilian states. The information regarding farm man-
agement supports the correlation between the decrease of
drug efﬁcacy in some yards calling for the implementation
of new strategies for parasite control.
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